Rezolute (RZLT) Other Operating Expenses (2011 - 2026)
Rezolute (RZLT) reported Other Operating Expenses of -$1.5 million for Q1 2026, up 19.86% on a YoY basis from -$1.2 million in Q1 2025, and up 69.79% sequentially from -$5.0 million in Q4 2025.
Rezolute (RZLT) Other Operating Expenses (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 12 years of Other Operating Expenses data on file, last reported at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 19.86% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$11.7 million (down 107.43% YoY), and the FY2025 full-year result was -$7.6 million, down 32.43% from the prior year.
- Other Operating Expenses improved to -$1.5 million in Q1 2026, from -$5.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$1.5 million in Q1 2026 to a low of -$5.0 million in Q4 2025.
- A 3-year average of -$2.5 million and a median of -$1.9 million in 2024 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses tumbled 167.75% in 2025 and rose 19.86% in 2026, its largest moves.
- Tracing RZLT's Other Operating Expenses over 3 years: stood at -$1.9 million in 2024, then tumbled by 167.75% to -$5.0 million in 2025, then surged by 69.79% to -$1.5 million in 2026.
- Business Quant data shows RZLT's Other Operating Expenses at -$1.5 million in Q1 2026, -$5.0 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | -4.96 Mn |
| Sep 30, 2025 | -3.32 Mn |
| Jun 30, 2025 | -1.96 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.85 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Jun 30, 2019 | 180,000.00 |
| Mar 31, 2019 | 11,000.00 |
| Dec 31, 2018 | 145,000.00 |
| Sep 30, 2018 | 23,000.00 |
| Jun 30, 2017 | -291,202.00 |
| Mar 31, 2017 | -382,535.00 |
| Dec 31, 2016 | -301,520.00 |
| Sep 30, 2016 | -256,596.00 |
| Jun 30, 2016 | -203,277.00 |
| Mar 31, 2016 | -302,731.00 |
| Dec 31, 2015 | -198,466.00 |
| Sep 30, 2015 | -205,183.00 |
| Jun 30, 2015 | -191,870.00 |